PHARMACY

Mylan launches its Crestor generic

BY David Salazar
PITTSBURGH —  Mylan last week launched its generic version of AstraZeneca’s Crestor (rosuvastatin calcium) tablets. The drug is indicated to treat high triglycerides in adults. 
 
Mylan’s generic will be available in 5-, 10-, 20- and 40-mg dosage strengths. For the 12 months ended May 31, the product had U.S. sales of $6.7 billion. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Apotex launches generic version of AstraZeneca’s Crestor

BY Gina Acosta

WESTON, Fla. — Apotex  has launched rosuvastatin calcium tablets, the generic equivalent of Crestor by AstraZeneca.

Apotex's rosuvastatin calcium tablets are now available in 5mg, 10mg, 20mg and 40mg strengths.

According to IMS Health, Crestor had approximately $6.6 billion in sales in the 12 months ending in January 2016.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva launches generic version of Imitrex injection

BY Gina Acosta

NEW YORK — Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products.

The product is AB rated and bioequivalent to Imitrex (sumatriptan succinate) Injection, and is available in strengths of 4 mg/0.5 mL and 6 mg/0.5 mL.

Both strengths are offered in cartons containing two autoinjectors, each with a prefilled 0.5 mL single-dose syringe.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?